The Minnesota Timberwolves haven't played a basketball game since earyl March due to the COVID-19 pandemic.
Despite the lack of action on the hardwood, the team is helping lead the way off the court. The Timberwolves, led by Vice President of Basketball Performance and Technology Robby Sikka, have been instrumental in the NBA and NBPA's research to develop a recently FDA-authorized COVID-19 test called SalivaDirect.
The test is one of the most cost-effective ways of detecting the virus, and has yielded a very small margin of error over the past few months. Sikka and the Wolves' medical staff began testing players and their families as they returned to the Twin Cities for individual workouts.